| 美国生物制药企业的发展路径研究及其启示 |
| |
| 引用本文： | 李天柱,银路,程跃.美国生物制药企业的发展路径研究及其启示[J].中国软科学,2010(5). |
| |
| 作者姓名： | 李天柱 银路 程跃 |
| |
| 作者单位： | 电子科技大学,经济与管理学院,四川,成都,610054 |
| |
| 摘 要： | 本文以生物制药产业为背景,选择安进、基因泰克等四家美国领先的生物制药公司为研究对象,通过分析这些企业的发展历程,总结归纳了"独立-借助传统大型企业"、"独立-合作发展"及"‘纽带-核心'渐进式发展"等的三条典型发展路径,并分析了不同企业选择不同发展路径的原因,进而针对不同的企业类型得出对我国生物技术企业发展路径选择的启示.
|
| 关 键 词： | 现代生物技术 发展路径 原因 启示 |
Study on the Development Paths of American Biotechnology Pharmaceutical Enterprises and Its Revelation |
| |
| LI Tian-zhu,YIN Lu,CHENG Yue.Study on the Development Paths of American Biotechnology Pharmaceutical Enterprises and Its Revelation[J].China Soft Science,2010(5). |
| |
| Authors: | LI Tian-zhu YIN Lu CHENG Yue |
| |
| Institution: | LI Tian-zhu,YIN Lu,CHENG Yue(School of Management , Economics,University of Electronic Science & Technology of China,Chengdu 610054,China) |
| |
| Abstract: | Under the background of biotechnology pharmaceutical industries,the paper chooses four American biotechnology pharmaceutical enterprises such as Amgen and Genentech as the research objects.Through analyzing the development course of these enterprises,we conclude three typical development paths that are self-development by means of traditional large-scale enterprises,self-integrated development and tie-core incremental development.Meanwhile,we analyze the reasons why different enterprise choose different pat... |
| |
| Keywords: | modern biotechnology development paths reason revelation |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《中国软科学》浏览原始摘要信息 |
| 点击此处可从《中国软科学》下载免费的PDF全文 |
|
